195 related articles for article (PubMed ID: 26390252)
21. Discoipyrroles A-D: isolation, structure determination, and synthesis of potent migration inhibitors from Bacillus hunanensis.
Hu Y; Potts MB; Colosimo D; Herrera-Herrera ML; Legako AG; Yousufuddin M; White MA; MacMillan JB
J Am Chem Soc; 2013 Sep; 135(36):13387-92. PubMed ID: 23984625
[TBL] [Abstract][Full Text] [Related]
22. The intracellular juxtamembrane domain of discoidin domain receptor 2 (DDR2) is essential for receptor activation and DDR2-mediated cancer progression.
Kim D; Ko P; You E; Rhee S
Int J Cancer; 2014 Dec; 135(11):2547-57. PubMed ID: 24740739
[TBL] [Abstract][Full Text] [Related]
23. Genetic landscape of metastatic and recurrent head and neck squamous cell carcinoma.
Hedberg ML; Goh G; Chiosea SI; Bauman JE; Freilino ML; Zeng Y; Wang L; Diergaarde BB; Gooding WE; Lui VW; Herbst RS; Lifton RP; Grandis JR
J Clin Invest; 2016 Jan; 126(1):169-80. PubMed ID: 26619122
[TBL] [Abstract][Full Text] [Related]
24. [The attachment manner of ubiquitin to proinflammatory molecule discoidin domain receptor 2].
Yu J; Bu X; Zhao H; Li X; Su J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Aug; 31(8):1077-80. PubMed ID: 26271983
[TBL] [Abstract][Full Text] [Related]
25. Abnormal Accumulation of Collagen Type I Due to the Loss of Discoidin Domain Receptor 2 (Ddr2) Promotes Testicular Interstitial Dysfunction.
Zhu CC; Tang B; Su J; Zhao H; Bu X; Li Z; Zhao J; Gong WD; Wu ZQ; Yao LB; Li W; Zhang YQ
PLoS One; 2015; 10(7):e0131947. PubMed ID: 26158267
[TBL] [Abstract][Full Text] [Related]
26. Identification of type II and III DDR2 inhibitors.
Richters A; Nguyen HD; Phan T; Simard JR; Grütter C; Engel J; Rauh D
J Med Chem; 2014 May; 57(10):4252-62. PubMed ID: 24754677
[TBL] [Abstract][Full Text] [Related]
27. An essential role of discoidin domain receptor 2 (DDR2) in osteoblast differentiation and chondrocyte maturation via modulation of Runx2 activation.
Zhang Y; Su J; Yu J; Bu X; Ren T; Liu X; Yao L
J Bone Miner Res; 2011 Mar; 26(3):604-17. PubMed ID: 20734453
[TBL] [Abstract][Full Text] [Related]
28. Src inhibitors act through different mechanisms in Non-Small Cell Lung Cancer models depending on EGFR and RAS mutational status.
Formisano L; D'Amato V; Servetto A; Brillante S; Raimondo L; Di Mauro C; Marciano R; Orsini RC; Cosconati S; Randazzo A; Parsons SJ; Montuori N; Veneziani BM; De Placido S; Rosa R; Bianco R
Oncotarget; 2015 Sep; 6(28):26090-103. PubMed ID: 26325669
[TBL] [Abstract][Full Text] [Related]
29. Downregulation of discoidin domain receptor 2 in A375 human melanoma cells reduces its experimental liver metastasis ability.
Badiola I; Villacé P; Basaldua I; Olaso E
Oncol Rep; 2011 Oct; 26(4):971-8. PubMed ID: 21701781
[TBL] [Abstract][Full Text] [Related]
30. Discoidin domain receptor 2 (DDR2) regulates proliferation of endochondral cells in mice.
Kawai I; Hisaki T; Sugiura K; Naito K; Kano K
Biochem Biophys Res Commun; 2012 Oct; 427(3):611-7. PubMed ID: 23022180
[TBL] [Abstract][Full Text] [Related]
31. DDR2 inhibition reduces migration and invasion of murine metastatic melanoma cells by suppressing MMP2/9 expression through ERK/NF-κB pathway.
Poudel B; Lee YM; Kim DK
Acta Biochim Biophys Sin (Shanghai); 2015 Apr; 47(4):292-8. PubMed ID: 25733533
[TBL] [Abstract][Full Text] [Related]
32. Actinomycin D identified as an inhibitor of discoidin domain receptor 2 interaction with collagen through an insect cell based screening of a drug compound library.
Siddiqui K; Kim GW; Lee DH; Shin HR; Yang EG; Lee NT; Yang BS
Biol Pharm Bull; 2009 Jan; 32(1):136-41. PubMed ID: 19122296
[TBL] [Abstract][Full Text] [Related]
33. Trafficking defects and loss of ligand binding are the underlying causes of all reported DDR2 missense mutations found in SMED-SL patients.
Ali BR; Xu H; Akawi NA; John A; Karuvantevida NS; Langer R; Al-Gazali L; Leitinger B
Hum Mol Genet; 2010 Jun; 19(11):2239-50. PubMed ID: 20223752
[TBL] [Abstract][Full Text] [Related]
34. The D2 period of collagen II contains a specific binding site for the human discoidin domain receptor, DDR2.
Leitinger B; Steplewski A; Fertala A
J Mol Biol; 2004 Dec; 344(4):993-1003. PubMed ID: 15544808
[TBL] [Abstract][Full Text] [Related]
35. DDR2 (discoidin domain receptor 2) suppresses osteoclastogenesis and is a potential therapeutic target in osteoporosis.
Zhang Y; Su J; Wu S; Teng Y; Yin Z; Guo Y; Li J; Li K; Yao L; Li X
Sci Signal; 2015 Mar; 8(369):ra31. PubMed ID: 25805889
[TBL] [Abstract][Full Text] [Related]
36. Collagen I enhances functional activities of human monocyte-derived dendritic cells via discoidin domain receptor 2.
Poudel B; Yoon DS; Lee JH; Lee YM; Kim DK
Cell Immunol; 2012; 278(1-2):95-102. PubMed ID: 23121981
[TBL] [Abstract][Full Text] [Related]
37. A deuterated analog of dasatinib disrupts cell cycle progression and displays anti-non-small cell lung cancer activity in vitro and in vivo.
Ling C; Chen G; Chen G; Zhang Z; Cao B; Han K; Yin J; Chu A; Zhao Y; Mao X
Int J Cancer; 2012 Nov; 131(10):2411-9. PubMed ID: 22362357
[TBL] [Abstract][Full Text] [Related]
38. A novel mutation in DDR2 causing spondylo-meta-epiphyseal dysplasia with short limbs and abnormal calcifications (SMED-SL) results in defective intra-cellular trafficking.
Al-Kindi A; Kizhakkedath P; Xu H; John A; Sayegh AA; Ganesh A; Al-Awadi M; Al-Anbouri L; Al-Gazali L; Leitinger B; Ali BR
BMC Med Genet; 2014 Apr; 15():42. PubMed ID: 24725993
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and biological evaluation of novel dasatinib analogues as potent DDR1 and DDR2 kinase inhibitors.
Liu L; Hussain M; Luo J; Duan A; Chen C; Tu Z; Zhang J
Chem Biol Drug Des; 2017 Mar; 89(3):420-427. PubMed ID: 27589335
[TBL] [Abstract][Full Text] [Related]
40. A synthetic lethality-based strategy to treat cancers harboring a genetic deficiency in the chromatin remodeling factor BRG1.
Oike T; Ogiwara H; Tominaga Y; Ito K; Ando O; Tsuta K; Mizukami T; Shimada Y; Isomura H; Komachi M; Furuta K; Watanabe S; Nakano T; Yokota J; Kohno T
Cancer Res; 2013 Sep; 73(17):5508-18. PubMed ID: 23872584
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
